46 , 47 Some doctors even found that patients who all had stage III or IV ovarian cancer with PSM actually had a longer 3-year survival than those without PSM, although this difference did not reach statistical significance. 48 However, because surgery and postoperative adjuvant therapy are often not involved in the long-term follow-up of patients who undergo resection of the incisional metastases, it is difficult to assess the impact of PSM on prognosis.
← all excerpts
Port Site Metastasis After Minimally Invasive Surgery in Gynecologic Malignancies: Two Case Reports and a Review of the Literature.
1
—
—